Suppr超能文献

在诊断样本中,SARS-CoV-2 的基因组和亚基因组 RNA 不是活跃复制的指标。

SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication.

机构信息

Geelong Centre for Emerging Infectious Diseases, Geelong, VIC, 3220, Australia.

Deakin University, Geelong, VIC, 3220, Australia.

出版信息

Nat Commun. 2020 Nov 27;11(1):6059. doi: 10.1038/s41467-020-19883-7.

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first detected in late December 2019 and has spread worldwide. Coronaviruses are enveloped, positive sense, single-stranded RNA viruses and employ a complicated pattern of virus genome length RNA replication as well as transcription of genome length and leader containing subgenomic RNAs. Although not fully understood, both replication and transcription are thought to take place in so-called double-membrane vesicles in the cytoplasm of infected cells. Here we show detection of SARS-CoV-2 subgenomic RNAs in diagnostic samples up to 17 days after initial detection of infection and provide evidence for their nuclease resistance and protection by cellular membranes suggesting that detection of subgenomic RNAs in such samples may not be a suitable indicator of active coronavirus replication/infection.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)于 2019 年 12 月底首次被发现,并已在全球范围内传播。冠状病毒为包膜、正链、单链 RNA 病毒,并采用复杂的病毒基因组长度 RNA 复制以及基因组长度和包含亚基因组 RNA 的转录模式。尽管尚未完全了解,但据认为,复制和转录均发生在受感染细胞的细胞质中的所谓双层膜泡内。在这里,我们在诊断样本中检测到 SARS-CoV-2 的亚基因组 RNA,其时间在感染初始检测之后长达 17 天,并提供了亚基因组 RNA 具有抗核酸酶性和受细胞膜保护的证据,这表明在这些样本中检测亚基因组 RNA 可能不是冠状病毒复制/感染的活性的合适指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c77/7695715/9296b8449f3f/41467_2020_19883_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验